Liver Forum 8

E-mail Print

The eighth Liver Forum was held on April 10, 2018 in Paris, France.
262 people attended Liver Forum 8. Of  those, 167 attended in-person, and 95 people registered for the webcast.

Materials:

Presentations:

Session I:
Session II: Breakout Sessions
  1. European Payer Perspective
    Clinical Development of New Technologies for Non-Alcoholic Steatohepatitis: NICE Perspective
    Francois Maignen, National Institute for Health and Care Excellence
      
    EMA-HTA Parallel Scientific Advice
    Samuel Mettam, Boehringer Ingelheim
  2. NASH Biomarkers Update
    CDER DDT Qualification: Impacts of 21st Century Cures Act, PDUFA VI, and Other Recent Changes
    Christopher Leptak, U.S. Food and Drug Administration

    NIMBLE Updates
    Roberto Calle, FNIH Biomarkers Consortium
    Rohit Loomba, University of California, San Diego

    LITMUS Updates
    Quentin Anstee, Newcastle University

    LITMUS: Update on Fibrosis Markers
    Detlef Schuppan, Mainz University Medical Center
  3. NASH Cirrhosis Working Group
    Working Group Overview
    Arun Sanyal, Virginia Commonwealth University
Session III: Breakout Session & Working Group Reports
Session IV: Combination Therapy